IRD — Opus Genetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Opus Genetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.4	24.8	42.7	50.5	30.3
Net Total Accounts Receivable
Net Total Receivables	—	—	4.85	2.33	5.77
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17.7	26.1	49	53.9	36.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.014	0.01	0.006	0	0.252
Total Assets	17.7	26.1	49	53.9	36.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.19	3.85	2.75	4.04	11.3
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	31.1	3.85	2.75	4.04	11.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-13.5	22.2	46.2	49.9	25.6
Total Liabilities & Shareholders' Equity	17.7	26.1	49	53.9	36.9
Total Common Shares Outstanding